Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease

NCT ID: NCT02345759

Last Updated: 2018-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dietary management of CKD patients proved important to postpone dialysis. Long-term compliance to protein-restricted diets was discussed. Psychological aspects involved in certain dietary behaviour have never been studied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The interest in dietary management resurged, since the high prevalence of revealed a major impact not only on morbidity, mortality, social activities and patients' quality of life, but also on health budget.

Although protein-restricted diets are used for more than a century in patients with advanced Chronic Kidney Disease (CKD), their efficacy and safety is still debatable. Enough evidence has being accumulated on their role in postponing dialysis initiation in compliant patients. Consequently, the long-term compliance to the diet is discussed. Psychological aspects of compliant patients are certainly involved. Identification of certain psychological predictors of dietary compliance could help to select the patients who are more likely to be compliant and therefore to benefit from such an intervention. Moreover, short-term or long-term psychological intervention addressing these factors could increase patient long-term compliance.

Accordingly, we are aiming to evaluate psychological characteristics of Chronic Kidney Disease patients in relation with their compliance to protein-restricted regimens.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychological Characteristics Involved in Dietary Compliance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Keto-diet group

Vegetarian very low protein regimen (0.3 g proteins/kg ideal body weight per day) supplemented with ketoanalogues of essential amino acids (Ketosteril®, Fresenius Kabi, Bad Homburg, Germany), 1 capsule for every 5 kg of ideal dry body weight per day.

No interventions assigned to this group

Conventional LPD group

0.6 g/kg per day, including high biological value proteins

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients
* stage 4+ CKD
* good nutritional status (Subjective Global Assessment score A/B and serum albumin ≥3.5 g/dL)
* declared potentially good compliance with a low protein diet and agreed to follow the monitoring schedule are considered for the program

Exclusion Criteria

* poorly controlled arterial blood pressure (≥145/85 mm Hg)
* uncontrolled diabetes mellitus
* other relevant comorbidities (heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy)
* uremic complications (pericarditis, polyneuropathy)
* feeding inability (anorexia, nausea)
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Anemia Working Group Romania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gabriel Mircescu, Professor of Nephrology

Role: STUDY_CHAIR

Spitalul Clinic de Nefrologie "Dr Carol Davila"

Liliana Garneata, MD, PhD

Role: STUDY_DIRECTOR

Spitalul Clinic de Nefrologie "Dr Carol Davila"

Cristina Drugau, MD

Role: PRINCIPAL_INVESTIGATOR

Spitalul Clinic de Nefrologie "Dr Carol Davila"

Evy Dehelean, Psychologist

Role: PRINCIPAL_INVESTIGATOR

International Health Care Systems Romania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spitalul Clinic de Nefrologie "Dr Carol Davila"

Bucharest, , Romania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Romania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liliana Garneata, MD, PhD

Role: CONTACT

+40722619358

Cristina Drugau

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liliana Garneata, MD, PhD

Role: primary

0722619358

Cristina Drugau, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AWG 5/2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.